168 related articles for article (PubMed ID: 9792150)
1. Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases.
Fordy C; Glover C; Davies MM; Allen-Mersh TG
Br J Cancer; 1998 Oct; 78(8):1058-60. PubMed ID: 9792150
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases.
Allen-Mersh TG; Glover C; Fordy C; Mathur P; Quinn H
Eur J Surg Oncol; 2000 Aug; 26(5):468-73. PubMed ID: 11016468
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
Rougier P; Laplanche A; Huguier M; Hay JM; Ollivier JM; Escat J; Salmon R; Julien M; Roullet Audy JC; Gallot D
J Clin Oncol; 1992 Jul; 10(7):1112-8. PubMed ID: 1296590
[TBL] [Abstract][Full Text] [Related]
4. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
5. Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study.
Fiorentini G; Cantore M; Rossi S; Vaira M; Tumolo S; Dentico P; Mambrini A; Bernardeschi P; Turrisi G; Giovanis P; Guadagni S; Valori V; De Simone M
In Vivo; 2006; 20(6A):707-9. PubMed ID: 17203750
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.
Martin JK; O'Connell MJ; Wieand HS; Fitzgibbons RJ; Mailliard JA; Rubin J; Nagorney DM; Tschetter LK; Krook JE
Arch Surg; 1990 Aug; 125(8):1022-7. PubMed ID: 2143063
[TBL] [Abstract][Full Text] [Related]
7. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
[TBL] [Abstract][Full Text] [Related]
10. Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity.
Davidson BS; Izzo F; Chase JL; DuBrow RA; Patt Y; Hohn DC; Curley SA
Am J Surg; 1996 Sep; 172(3):244-7. PubMed ID: 8862076
[TBL] [Abstract][Full Text] [Related]
11. Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil.
Buroker T; Samson M; Correa J; Fraile R; Vaitkevicius VK
Cancer Treat Rep; 1976 Sep; 60(9):1277-9. PubMed ID: 138480
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
[TBL] [Abstract][Full Text] [Related]
13. Regional chemotherapy for colorectal liver metastases: thirty years without patient benefit.
Begos DG; Ballantyne GH
J Surg Oncol; 1994 Jul; 56(3):139-44. PubMed ID: 8028342
[No Abstract] [Full Text] [Related]
14. Re: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.
Anand A; Anand N; Anand A
J Natl Cancer Inst; 1996 Jun; 88(12):838-9. PubMed ID: 8637052
[No Abstract] [Full Text] [Related]
15. Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil.
Bilchik AJ; Wood TF; Chawla SP; Rose DM; Chung MH; Stern SS; Foshag LJ; Ramming KP
Clin Colorectal Cancer; 2001 May; 1(1):36-42. PubMed ID: 12445377
[TBL] [Abstract][Full Text] [Related]
16. Hepatic artery chemotherapy and colorectal liver metastases.
Brooks A; Clingan P; Morris D
Lancet; 2003 May; 361(9370):1742; author reply 1743. PubMed ID: 12767759
[No Abstract] [Full Text] [Related]
17. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.
; Piedbois P; Buyse M; Kemeny N; Rougier P; Carlson R; Allen-Mersh T; O'Connell M; Chang A; Sondak V; Kemeny M; Levy E
J Natl Cancer Inst; 1996 Mar; 88(5):252-8. PubMed ID: 8614003
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.
Kemeny N; Cohen A; Seiter K; Conti JA; Sigurdson ER; Tao Y; Niedzwiecki D; Botet J; Budd A
J Clin Oncol; 1993 Feb; 11(2):330-5. PubMed ID: 8426211
[TBL] [Abstract][Full Text] [Related]
19. Complications of hepatic artery infusion: a review of 4580 reported cases.
Barnett KT; Malafa MP
Int J Gastrointest Cancer; 2001; 30(3):147-60. PubMed ID: 12540027
[TBL] [Abstract][Full Text] [Related]
20. Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues.
Patt YZ
J Clin Oncol; 1993 May; 11(5):815-9. PubMed ID: 8487044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
